A review of the evidence for the efficacy and safety of trazodone in insomnia

Journal of Clinical Psychiatry

Volumn 66, Issue 4, 2005, Pages 469-476

  Mendelson, Wallace B ^{a,b,c,d,e,f,g,h,i,j}  

^a UNIVERSITY OF CHICAGO   (United States)

^b VivoMetrics Inc   (United States)

^c Sepracor   (United States)

^d SANOFI   (France)

^e Neurocrine   (United States)

^f Aventis Gencell   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h King   (United States)

ⁱ Elan   (United States)

^j NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRAZODONE; ZOLPIDEM TARTRATE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; EDEMA; FALLING; GERIATRIC PATIENT; HEADACHE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; INJURY; INSOMNIA; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; NAUSEA; ORTHOSTATIC HYPOTENSION; POLYSOMNOGRAPHY; POTASSIUM CURRENT; PRIAPISM; PRIORITY JOURNAL; PRURITUS; PSYCHOMOTOR DISORDER; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SLEEP TIME; SYNCOPE; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 17844392614     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0409     Document Type: Review

References (52)

1. IMS Health. National Prescription Audit Plus 2002. Available at http://www.imshealth.com
2. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999;22:371-375
3. Haria M, Fitton A, McTavish D. Trazodone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 1994;4:331-355
4. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000;23(suppl 1):S23-S30
5. Mashiko H, Niwa S, Kumashiro H, et al. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent. Psychiatry Clin Neurosci 1999;53:193-194
6. Gemer RH. Geriatric depression and treatment with trazodone. Psychopathology 1987;20(suppl 1):82-91
7. Bayer AJ, Pathy MS, Ankier SI. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol 1983;16:371-376
8. Kaynak H, Kaynak D, Gozukirmizi E, et al. The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med 2004;5:15-20
9. Saletu-Zyhlarz GM, Anderer P, Arnold O, et al. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology 2003;48:194-208
10. Ather SA, Ankier SI, Middleton RS. A double-blind evaluation of trazodone in the treatment of depression in the elderly. Br J Clin Pract 1985;39:192-199
11. Blacker R, Shanks NJ, Chapman N, et al. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline. Psychopharmacology (Berl) 1988;95(suppl):S18-S24
12. Davey A. A comparison of two oral dosage regimens of 150 mg trazodone in the treatment of depression in general practice. Psychopharmacology (Berl) 1988;95(suppl):S25-S30
13. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharmacol 1998;13:191-198
14. Haffmans PM, Vos MS. The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry 1999;14:167-171
15. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry 1994;151:1069-1072
16. Ware JC, Pittard JT. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 1990;51(9, suppl):18-22
17. Yamadera H, Suzuki H, Nakamura S, et al. Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers. Psychiatry Clin Neurosci 1999;53:189-191
18. Montgomery I, Oswald I, Morgan K, et al. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 1983;16:139-144
19. Botros WA, Ankier SI, Priest RG, et al. Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone. Br J Psychiatry 1989;155:479-482
20. Moon CA, Davey A. The efficacy and residual effects of trazodone (150 mg nocte) and mianserin in the treatment of depressed general practice patients. Psychopharmacology (Berl) 1988;95(suppl):S7-S13
21. Mouret J, Lemoine P, Minuit MP, et al. Effects of trazodone on the sleep of depressed subjects: a polygraphic study. Psychopharmacology (Berl) 1988;95(suppl):S37-S43
22. Parrino L, Spaggiari MC, Boselli M, et al. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology (Berl) 1994;116:389-395
23. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 2001;44:139-149
24. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:249-260
25. Scharf MB, Sachais BA. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 1990;51(9, suppl):13-17
26. van Bemmel AL, Havermans RG, van Diest R. Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology (Berl) 1992;107:569-574
27. Maxmen JS. Antidepressants. In: Maxmen JS, Ward NC, eds. Psychotropic Drugs: Fast Facts. New York, NY: WW Norton & Company; 1991:57-97
28. Feighner JP, Boyer WF. Overview of USA controlled trials of trazodone in clinical depression. Psychopharmacology (Berl) 1988;95(suppl): S50-S53
29. Gerner R, Estabrook W, Steuer J, et al. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry 1980;41:216-220
30. Beasley CM Jr, Dornseif BE, Pultz JA, et al. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 1991;52:294-299
31. Al Yassiri MM, Bridges PK. Trazodone efficacy and safety in endogenous depression: a double blind comparison with imipramine. Neuropharmacology 1980;19:1191-1193
32. Feighner JP. Trazodone, a triazolopyridine derivative, in primary depressive disorder. J Clin Psychiatry 1980;41:250-255
33. Fabre LF. United States experience and perspectives with trazodone. Clin Neuropharmacol 1989;12(suppl 1):S11-S17
34. Sakulsripong M, Curran HV, Lader M. Does tolerance develop to the sedative and amnesic effects of antidepressants? a comparison of amitriptyline, trazodone and placebo. Eur J Clin Pharmacol 1991;40:43-48
35. Metz A, Shader RI. Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. Int Clin Psychopharmacol 1990;5:191-194
36. Himmelhoch J. A comparative study of trazodone and doxepin in the treatment of major depressive disorder. Curr Ther Res 1986;39:1017-1026
37. Hayes RL, Gemer RH, Fairbanks L, et al. ECG findings in geriatric depressives given trazodone, placebo, or imipramine. J Clin Psychiatry 1983;44:180-183
38. Nambudiri DE, Mirchandani IC, Young RC. Two more cases of trazodone-related syncope in the elderly [letter]. J Geriatr Psychiatry Neurol 1989;2:225
39. Spivak B, Radvan M, Shine M. Postural hypotension with syncope possibly precipitated by trazodone [letter]. Am J Psychiatry 1987;144:1512-1513
40. Janowsky D, Curtis G, Zisook S, et al. Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry 1983;140:796-797
41. Aronson MD, Hafez H. A case of trazodone-induced ventricular tachycardia. J Clin Psychiatry 1986;47:388-389
42. Mazur A, Strasberg B, Kusniec J, et al. QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination. Int J Cardiol 1995;52:27-29
43. Pohl R, Bridges M, Rainey JM Jr, et al. Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease [letter]. J Clin Psychopharmacol 1986;6:380-381
44. Tarantino R, Appleton N, Lansdell R. Effect of Trazodone on hERG Channel Current and QT Interval. Eur J Pharmacol. In press
45. Robinson DS, Corcella J, Feighner JP, et al. A comparison of trazodone, amoxapine and maprotiline in the treatment of endogenous depression: results of a multicenter study. Curr Ther Res 1984;35:549-560
46. Warner MD, Peabody CA, Whiteford HA, et al. Trazodone and priapism. J Clin Psychiatry 1987;48:244-245
47. Thompson JW Jr, Ware MR, Blashfield RK. Psychotropic medication and priapism: a comprehensive review. J Clin Psychiatry 1990;51:430-433
48. Carson CC III, Mino RD. Priapism associated with trazodone therapy. J Urol 1988;139:369-370
49. Jones D, Gershon S, Sitaram N, et al. Sleep and depression. Psychopathology 1987;20(suppl 1):20-31
50. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425-432
51. Foley DJ, Monjan A, Simonsick EM, et al. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999;22(suppl 2):S366-S372
52. Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years. J Am Geriatr Soc 2000;48:1234-1240